Back to DYN

Atlas Venture Life Science Advisors, LLC → DYN

Atlas Venture Life Science Advisors, LLC DYN Position History

Dyne Therapeutics, Inc. • Healthcare

Quarters held
5
Latest value
$55.4M
Q3 2026
Peak value
$178.6M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$115.5M
Q4 2025$178.6M
Q1 2026$165.5M
Q2 2026$151M
Q3 2026$55.4M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$55.4M3.44M——
Q2 2026$151M6.80M——
Q1 2026$165.5M9.13M——
Q4 2025$178.6M9.13M——
Q3 2025$115.5M9.13M——

Other funds holding DYN

Other Atlas Venture Life Science Advisors, LLC positions

KYMR

Kymera Therapeutics, Inc.

$381.3M
KYMR

Kymera Therapeutics, Inc.

$362.6M
KYMR

Kymera Therapeutics, Inc.

$326.5M
KYMR

Kymera Therapeutics, Inc.

$318.3M
KYMR

Kymera Therapeutics, Inc.

$277.1M
IRON

Disc Medicine, Inc.

$141.6M
SION

Sionna Therapeutics, Inc.

$131.8M
SION

Sionna Therapeutics, Inc.

$123.2M